Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Group ACYW135 Meningococcal Polysaccharide Vaccine players cover Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Zhejiang Tianyuan Biopharmaceutical Co., Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Group ACYW135 Meningococcal Polysaccharide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, with both quantitative and qualitative data, to help readers understand how the Group ACYW135 Meningococcal Polysaccharide Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Group ACYW135 Meningococcal Polysaccharide Vaccine market and forecasts the market size by Type (Class I Vaccines and Class II Vaccines,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Group ACYW135 Meningococcal Polysaccharide Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Group ACYW135 Meningococcal Polysaccharide Vaccine market size (sales and revenue) and CAGR, Group ACYW135 Meningococcal Polysaccharide Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Group ACYW135 Meningococcal Polysaccharide Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Group ACYW135 Meningococcal Polysaccharide Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Group ACYW135 Meningococcal Polysaccharide Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, CanSino Biologics AG, Yuxi Watson Biotechnology Co., Ltd and Hualan Biovaccine Co., Ltd, etc.
Chapter 14: Research Findings and Conclusion
The global market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Group ACYW135 Meningococcal Polysaccharide Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Group ACYW135 Meningococcal Polysaccharide Vaccine players cover Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Zhejiang Tianyuan Biopharmaceutical Co., Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Group ACYW135 Meningococcal Polysaccharide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, with both quantitative and qualitative data, to help readers understand how the Group ACYW135 Meningococcal Polysaccharide Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Group ACYW135 Meningococcal Polysaccharide Vaccine market and forecasts the market size by Type (Class I Vaccines and Class II Vaccines,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Class I Vaccines
- Class II Vaccines
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi-Pasteur
- Walvax Biotechnology
- Chengdu Kanghua Biological Products Co., Ltd
- Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
- Zhejiang Tianyuan Biopharmaceutical Co., Ltd
- Beijing Institute of Biological Products Co., Ltd
- CanSino Biologics AG
- Yuxi Watson Biotechnology Co., Ltd
- Hualan Biovaccine Co., Ltd
- Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
Chapter 1: Scope of Group ACYW135 Meningococcal Polysaccharide Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Group ACYW135 Meningococcal Polysaccharide Vaccine market size (sales and revenue) and CAGR, Group ACYW135 Meningococcal Polysaccharide Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Group ACYW135 Meningococcal Polysaccharide Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Group ACYW135 Meningococcal Polysaccharide Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Group ACYW135 Meningococcal Polysaccharide Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, CanSino Biologics AG, Yuxi Watson Biotechnology Co., Ltd and Hualan Biovaccine Co., Ltd, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Group ACYW135 Meningococcal Polysaccharide Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Group ACYW135 Meningococcal Polysaccharide Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Type
2.2.1 Class I Vaccines
2.2.2 Class II Vaccines
2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Type (2017-2022)
2.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Application (2017-2022)
3 GLOBAL GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE BY COMPANY
3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Company (2020-2022)
3.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players Group ACYW135 Meningococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue by Geographic Region
4.2 World Historic Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue by Country/Region
4.3 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
4.4 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
4.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)
5.1.2 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
5.2 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
5.3 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022)
6.1.2 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
6.2 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
6.3 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine by Country
7.1.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)
7.1.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
7.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
7.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of Group ACYW135 Meningococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors
11.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecast by Region (2023-2028)
12.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecast by Type
12.7 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi-Pasteur
13.1.1 Sanofi-Pasteur Company Information
13.1.2 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi-Pasteur Main Business Overview
13.1.5 Sanofi-Pasteur Latest Developments
13.2 Walvax Biotechnology
13.2.1 Walvax Biotechnology Company Information
13.2.2 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Walvax Biotechnology Main Business Overview
13.2.5 Walvax Biotechnology Latest Developments
13.3 Chengdu Kanghua Biological Products Co., Ltd
13.3.1 Chengdu Kanghua Biological Products Co., Ltd Company Information
13.3.2 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Chengdu Kanghua Biological Products Co., Ltd Main Business Overview
13.3.5 Chengdu Kanghua Biological Products Co., Ltd Latest Developments
13.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
13.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
13.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Main Business Overview
13.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Latest Developments
13.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
13.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Company Information
13.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Main Business Overview
13.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Latest Developments
13.6 Beijing Institute of Biological Products Co., Ltd
13.6.1 Beijing Institute of Biological Products Co., Ltd Company Information
13.6.2 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Beijing Institute of Biological Products Co., Ltd Main Business Overview
13.6.5 Beijing Institute of Biological Products Co., Ltd Latest Developments
13.7 CanSino Biologics AG
13.7.1 CanSino Biologics AG Company Information
13.7.2 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.7.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CanSino Biologics AG Main Business Overview
13.7.5 CanSino Biologics AG Latest Developments
13.8 Yuxi Watson Biotechnology Co., Ltd
13.8.1 Yuxi Watson Biotechnology Co., Ltd Company Information
13.8.2 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Yuxi Watson Biotechnology Co., Ltd Main Business Overview
13.8.5 Yuxi Watson Biotechnology Co., Ltd Latest Developments
13.9 Hualan Biovaccine Co., Ltd
13.9.1 Hualan Biovaccine Co., Ltd Company Information
13.9.2 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hualan Biovaccine Co., Ltd Main Business Overview
13.9.5 Hualan Biovaccine Co., Ltd Latest Developments
13.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
13.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Company Information
13.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Main Business Overview
13.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Group ACYW135 Meningococcal Polysaccharide Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Group ACYW135 Meningococcal Polysaccharide Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Type
2.2.1 Class I Vaccines
2.2.2 Class II Vaccines
2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Type (2017-2022)
2.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Application (2017-2022)
3 GLOBAL GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE BY COMPANY
3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Company (2020-2022)
3.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players Group ACYW135 Meningococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue by Geographic Region
4.2 World Historic Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue by Country/Region
4.3 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
4.4 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
4.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)
5.1.2 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
5.2 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
5.3 Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022)
6.1.2 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
6.2 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
6.3 APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine by Country
7.1.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)
7.1.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
7.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
7.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of Group ACYW135 Meningococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors
11.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecast by Region (2023-2028)
12.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecast by Type
12.7 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi-Pasteur
13.1.1 Sanofi-Pasteur Company Information
13.1.2 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi-Pasteur Main Business Overview
13.1.5 Sanofi-Pasteur Latest Developments
13.2 Walvax Biotechnology
13.2.1 Walvax Biotechnology Company Information
13.2.2 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Walvax Biotechnology Main Business Overview
13.2.5 Walvax Biotechnology Latest Developments
13.3 Chengdu Kanghua Biological Products Co., Ltd
13.3.1 Chengdu Kanghua Biological Products Co., Ltd Company Information
13.3.2 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Chengdu Kanghua Biological Products Co., Ltd Main Business Overview
13.3.5 Chengdu Kanghua Biological Products Co., Ltd Latest Developments
13.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
13.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
13.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Main Business Overview
13.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Latest Developments
13.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
13.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Company Information
13.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Main Business Overview
13.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Latest Developments
13.6 Beijing Institute of Biological Products Co., Ltd
13.6.1 Beijing Institute of Biological Products Co., Ltd Company Information
13.6.2 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Beijing Institute of Biological Products Co., Ltd Main Business Overview
13.6.5 Beijing Institute of Biological Products Co., Ltd Latest Developments
13.7 CanSino Biologics AG
13.7.1 CanSino Biologics AG Company Information
13.7.2 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.7.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CanSino Biologics AG Main Business Overview
13.7.5 CanSino Biologics AG Latest Developments
13.8 Yuxi Watson Biotechnology Co., Ltd
13.8.1 Yuxi Watson Biotechnology Co., Ltd Company Information
13.8.2 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Yuxi Watson Biotechnology Co., Ltd Main Business Overview
13.8.5 Yuxi Watson Biotechnology Co., Ltd Latest Developments
13.9 Hualan Biovaccine Co., Ltd
13.9.1 Hualan Biovaccine Co., Ltd Company Information
13.9.2 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hualan Biovaccine Co., Ltd Main Business Overview
13.9.5 Hualan Biovaccine Co., Ltd Latest Developments
13.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
13.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Company Information
13.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
13.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Main Business Overview
13.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Class I Vaccines
Table 4. Major Players of Class II Vaccines
Table 5. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2022)
Table 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players Group ACYW135 Meningococcal Polysaccharide Vaccine Products Offered
Table 22. Group ACYW135 Meningococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Group ACYW135 Meningococcal Polysaccharide Vaccine
Table 66. Key Market Challenges & Risks of Group ACYW135 Meningococcal Polysaccharide Vaccine
Table 67. Key Industry Trends of Group ACYW135 Meningococcal Polysaccharide Vaccine
Table 68. Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors List
Table 71. Group ACYW135 Meningococcal Polysaccharide Vaccine Customer List
Table 72. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Forecast by Region
Table 74. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi-Pasteur Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 94. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi-Pasteur Main Business
Table 96. Sanofi-Pasteur Latest Developments
Table 97. Walvax Biotechnology Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 99. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Walvax Biotechnology Main Business
Table 101. Walvax Biotechnology Latest Developments
Table 102. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 104. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Chengdu Kanghua Biological Products Co., Ltd Main Business
Table 106. Chengdu Kanghua Biological Products Co., Ltd Latest Developments
Table 107. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 109. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Main Business
Table 111. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Latest Developments
Table 112. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 114. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Main Business
Table 116. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Latest Developments
Table 117. Beijing Institute of Biological Products Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 119. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Beijing Institute of Biological Products Co., Ltd Main Business
Table 121. Beijing Institute of Biological Products Co., Ltd Latest Developments
Table 122. CanSino Biologics AG Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 124. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. CanSino Biologics AG Main Business
Table 126. CanSino Biologics AG Latest Developments
Table 127. Yuxi Watson Biotechnology Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 129. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Yuxi Watson Biotechnology Co., Ltd Main Business
Table 131. Yuxi Watson Biotechnology Co., Ltd Latest Developments
Table 132. Hualan Biovaccine Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 134. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Hualan Biovaccine Co., Ltd Main Business
Table 136. Hualan Biovaccine Co., Ltd Latest Developments
Table 137. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 139. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Main Business
Table 141. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Latest Developments
Table 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Group ACYW135 Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Class I Vaccines
Table 4. Major Players of Class II Vaccines
Table 5. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2022)
Table 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players Group ACYW135 Meningococcal Polysaccharide Vaccine Products Offered
Table 22. Group ACYW135 Meningococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Group ACYW135 Meningococcal Polysaccharide Vaccine
Table 66. Key Market Challenges & Risks of Group ACYW135 Meningococcal Polysaccharide Vaccine
Table 67. Key Industry Trends of Group ACYW135 Meningococcal Polysaccharide Vaccine
Table 68. Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors List
Table 71. Group ACYW135 Meningococcal Polysaccharide Vaccine Customer List
Table 72. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Forecast by Region
Table 74. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi-Pasteur Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 94. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi-Pasteur Main Business
Table 96. Sanofi-Pasteur Latest Developments
Table 97. Walvax Biotechnology Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 99. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Walvax Biotechnology Main Business
Table 101. Walvax Biotechnology Latest Developments
Table 102. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 104. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Chengdu Kanghua Biological Products Co., Ltd Main Business
Table 106. Chengdu Kanghua Biological Products Co., Ltd Latest Developments
Table 107. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 109. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Main Business
Table 111. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Latest Developments
Table 112. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 114. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Main Business
Table 116. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Latest Developments
Table 117. Beijing Institute of Biological Products Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 119. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Beijing Institute of Biological Products Co., Ltd Main Business
Table 121. Beijing Institute of Biological Products Co., Ltd Latest Developments
Table 122. CanSino Biologics AG Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 124. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. CanSino Biologics AG Main Business
Table 126. CanSino Biologics AG Latest Developments
Table 127. Yuxi Watson Biotechnology Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 129. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Yuxi Watson Biotechnology Co., Ltd Main Business
Table 131. Yuxi Watson Biotechnology Co., Ltd Latest Developments
Table 132. Hualan Biovaccine Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 134. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Hualan Biovaccine Co., Ltd Main Business
Table 136. Hualan Biovaccine Co., Ltd Latest Developments
Table 137. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Basic Information, Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Offered
Table 139. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Main Business
Table 141. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 2. Group ACYW135 Meningococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Class I Vaccines
Figure 10. Product Picture of Class II Vaccines
Figure 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type in 2021
Figure 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Group ACYW135 Meningococcal Polysaccharide Vaccine Consumed in Hospital
Figure 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Group ACYW135 Meningococcal Polysaccharide Vaccine Consumed in Clinic
Figure 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021
Figure 19. Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 63. Industry Chain Structure of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 1. Picture of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 2. Group ACYW135 Meningococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Class I Vaccines
Figure 10. Product Picture of Class II Vaccines
Figure 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type in 2021
Figure 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Group ACYW135 Meningococcal Polysaccharide Vaccine Consumed in Hospital
Figure 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Group ACYW135 Meningococcal Polysaccharide Vaccine Consumed in Clinic
Figure 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021
Figure 19. Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 63. Industry Chain Structure of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
